USD 11.45
(1.51%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 26.74 Million | 23.51 Million | 65.26 Million | 46.12 Million | 37.75 Million | 18.83 Million |
Net Income | 14.8 Million | -59.83 Million | -7.7 Million | 18.81 Million | 29.42 Million | -6.39 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 9955.00 | 614.12 Thousand | -764.49 Thousand | -327.54 Thousand | -103.19 Thousand | -199.18 Thousand |
Other non-cash items | 11.93 Million | 82.73 Million | 73.73 Million | 27.64 Million | 8.43 Million | 25.42 Million |
Investing Cash Flow | 13.88 Million | -11.52 Million | 33.02 Million | 38.33 Million | 26.31 Million | -8.2 Million |
Investments in PPE | -5.00 | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -944 Million | -1.25 Billion | -1.25 Billion | -368.04 Million | -1.44 Billion | -1.98 Billion |
Sales/Maturities of investments | 930.11 Million | 1.24 Billion | 1.28 Billion | 406.38 Million | 1.47 Billion | 1.97 Billion |
Other Investing Activities | 27.76 Million | - | -1.00 | - | - | - |
Financing Cash Flow | -26.99 Million | -24.07 Million | -67.47 Million | -44.86 Million | -37.11 Million | -21.02 Million |
Debt repayment | -4.48 Million | -9801.00 | -41.74 Million | -18.53 Million | -10.78 Million | -632.09 Thousand |
Dividends payments | -22.5 Million | -24.08 Million | -25.73 Million | -26.33 Million | -26.33 Million | -20.8 Million |
Common Stock Repurchased | - | - | - | - | - | -854.48 Thousand |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -4.48 Million | 9801.00 | -41.74 Million | 36.00 | -10.78 Million | 632.09 Thousand |
Accounts receivables | -555.7 Thousand | -1.29 Million | 222.23 Thousand | 315.16 Thousand | 8144.00 | 1479.00 |
Accounts payables | -37.84 Thousand | -148.93 Thousand | -157.58 Thousand | -79.63 Thousand | -165.38 Thousand | -235.13 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | 603.5 Thousand | 2.05 Million | -829.14 Thousand | -563.06 Thousand | 54.04 Thousand | 34.47 Thousand |
Cash at beginning of period | 1.13 Million | 1.68 Million | 3.89 Million | 2.63 Million | 1.99 Million | 4.42 Million |
Cash at end of period | 885 Thousand | 1.13 Million | 1.68 Million | 3.89 Million | 2.63 Million | 2.23 Million |
Capital Expenditure | -5.00 | - | - | - | - | - |
Effect of forex changes on cash | -13.88 Million | 11.52 Million | -33.02 Million | -38.33 Million | -26.31 Million | - |
Net cash flow / Change in cash | -246.26 Thousand | -557 Thousand | -2.21 Million | 1.26 Million | 640 Thousand | -2.19 Million |
Free Cash Flow | 26.74 Million | 23.51 Million | 65.26 Million | 46.12 Million | 37.75 Million | 18.83 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.54 Million | -1.54 Million | 11.04 Million | 14.8 Million | 5.52 Million | 3.75 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -496.09 Thousand | -496.09 Thousand | 1.86 Million | 9955.00 | 933.52 Thousand | -1.85 Million |
Other non-cash items | 25.02 Million | 25.02 Million | -3.65 Million | 11.93 Million | 3.76 Million | 3.98 Million |
Investing Cash Flow | 35.77 Million | - | 13.12 Million | 13.88 Million | - | 759.62 Thousand |
Investments in PPE | 3.00 | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -421.17 Million | - | -401.62 Million | -944 Million | - | -542.37 Million |
Sales/Maturities of investments | 456.94 Million | - | 386.98 Million | 930.11 Million | - | 543.13 Million |
Other Investing Activities | - | - | 27.76 Million | 27.76 Million | - | - |
Financing Cash Flow | -23.03 Million | -23.03 Million | -20.8 Million | -26.99 Million | -10.4 Million | -6.19 Million |
Debt repayment | -34.85 Million | - | -9.47 Million | -4.48 Million | - | -4.98 Million |
Dividends payments | -11.22 Million | -5.61 Million | -11.32 Million | -22.5 Million | -5.66 Million | -11.17 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -17.42 Million | -17.42 Million | -4.73 Million | -4.48 Million | -4.73 Million | 2.49 Million |
Accounts receivables | 1.02 Million | 1.02 Million | -385.95 Thousand | -555.7 Thousand | -172.79 Thousand | -169.75 Thousand |
Accounts payables | -43.93 Thousand | - | -214.77 Thousand | -37.84 Thousand | - | 176.93 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -1.52 Million | -1.52 Million | 2.46 Million | 603.5 Thousand | 1.1 Million | -1.86 Million |
Cash at beginning of period | -39.61 Million | - | - | 1.13 Million | - | - |
Cash at end of period | -3.9 Million | -61 Thousand | 970.13 Thousand | 885 Thousand | -184 Thousand | 463.58 Thousand |
Capital Expenditure | 3.00 | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | -13.88 Million | - | - |
Net cash flow / Change in cash | 35.71 Million | -61 Thousand | 970.13 Thousand | -246.26 Thousand | -184 Thousand | 463.58 Thousand |
Free Cash Flow | 22.97 Million | 22.97 Million | 8.65 Million | 26.74 Million | 10.21 Million | 5.89 Million |
BIO
BENGALASM
ZRSEF
8021
TRT
TRI